These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36479564)

  • 21. Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Tang X; Li R; Jing Q; Liu Y; Liu P
    PLoS One; 2015; 10(6):e0129718. PubMed ID: 26067296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.
    Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
    Clin Drug Investig; 2015 Dec; 35(12):777-84. PubMed ID: 26387028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.
    Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Fleeman N; McEntee J; Dundar Y; Richardson M; Fisher M
    Health Technol Assess; 2015 Apr; 19(29):1-130. PubMed ID: 25896573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Danhong Injection Combined with Naoxintong Capsule in Acute Coronary Syndrome Patients Undergoing PCI Operation: Study for a Randomized Controlled and Double-Blind Trial.
    Zhao S; Tang Y; Cai H; Liu W; Zhang L; Chen D; Chen B
    Evid Based Complement Alternat Med; 2018; 2018():8485472. PubMed ID: 29707035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of recombinant human brain natriuretic peptide on the prognosis of patients with acute anterior myocardial infarction undergoing primary percutaneous coronary intervention: a prospective, multi-center, randomized clinical trial.
    Miao ZL; Hou AJ; Zang HY; Huang RG; Zheng XQ; Lin HL; Wang W; Hou P; Xia F; Li ZQ
    J Thorac Dis; 2017 Jan; 9(1):54-63. PubMed ID: 28203406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of Chinese herbs for supplementing qi, nourishing yin and activating blood circulation on heart function of patients with acute coronary syndrome after percutaneous coronary intervention.
    Liu HY; Wang W; Shi DZ; Ge JB; Zhang L; Peng J; Wang CL; Wang PL
    Chin J Integr Med; 2012 Jun; 18(6):423-30. PubMed ID: 22382523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Chinese Medicine on No or Slow Reflow after Percutaneous Coronary Intervention in Myocardial Infarction Patients: A Systematic Review and Meta-Analysis.
    Zhang XY; Sun Y; Yang XY; Hu JY; Zheng R; Chen SQ; Li M; Li CY; Jiang Y; Liu S; Zhao C; Xing YW; Shang HC
    Chin J Integr Med; 2020 Mar; 26(3):227-234. PubMed ID: 31093877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosuvastatin reduces ischemia-reperfusion injury in patients with acute coronary syndrome treated with percutaneous coronary intervention.
    Jiang F; Yang J; Zhang L; Li R; Zhuo L; Sun L; Zhao Q
    Clin Cardiol; 2014 Sep; 37(9):530-5. PubMed ID: 25156269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Danhong injection mobilizes endothelial progenitor cells to repair vascular endothelium injury via upregulating the expression of Akt, eNOS and MMP-9.
    Hu Z; Wang H; Fan G; Zhang H; Wang X; Mao J; Zhao Y; An Y; Huang Y; Li C; Chang L; Chu X; LiLi ; Li Y; Zhang Y; Qin G; Gao X; Zhang B
    Phytomedicine; 2019 Aug; 61():152850. PubMed ID: 31035054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
    Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of TCMI in Patients With Combined Coronary Heart Disease and Heart Failure: A Systematic Review and Network Meta-Analysis.
    Wei P; Yang K; Long D; Tan Y; Xing W; Li X; Wu H; Liu H
    Front Pharmacol; 2021; 12():741261. PubMed ID: 34899296
    [No Abstract]   [Full Text] [Related]  

  • 32. Sodium Tanshinone II A Sulfonate for Coronary Heart Disease: A Systematic Review of Randomized Controlled Trials.
    Yu ML; Li SM; Gao X; Li JG; Xu H; Chen KJ
    Chin J Integr Med; 2020 Mar; 26(3):219-226. PubMed ID: 29752695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immediate versus deferred percutaneous coronary intervention for patients with acute coronary syndrome: A meta-analysis of randomized controlled trials.
    Li W; He W; Zhou Y; Guo Y
    PLoS One; 2020; 15(7):e0234655. PubMed ID: 32614851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term effect of verapamil on coronary no-reflow associated with percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Su Q; Li L; Liu Y
    Clin Cardiol; 2013 Aug; 36(8):E11-6. PubMed ID: 23749333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects on Suxiao Jiuxin Pills in the Treatment of Patients with Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention: A Multicenter Randomized Double-Blind Placebo-Controlled Trial.
    Shen Z; Chen T; Deng B; Fan M; Hua J; Zhang M; Wang X
    J Altern Complement Med; 2020 Nov; 26(11):1055-1063. PubMed ID: 32716206
    [No Abstract]   [Full Text] [Related]  

  • 36. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.
    Liu HL; Yang Y; Yang SL; Luo JP; Li H; Jing LM; Shen ZQ
    Clin Ther; 2013 Mar; 35(3):261-72. PubMed ID: 23410871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Xinyue Capsule for Coronary Artery Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Jiang Z; Qu H; Zhang Y; Zhang F; Xiao W; Shi D; Gao Z; Chen K
    Evid Based Complement Alternat Med; 2021; 2021():6695868. PubMed ID: 33897802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Improvement of Cardiac and Endothelial Functions of Xue-Fu-Zhu-Yu Decoction for Patients with Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Chen S; Wu X; Li T; Cheng W; Han X; Li Y; Wang B; Teng Y; Zhao M; Wang Y
    Evid Based Complement Alternat Med; 2022; 2022():2671343. PubMed ID: 35186096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of five traditional Chinese medicine injections for treating heart failure with reduced and mildly reduced ejection fraction: Bayesian network meta-analysis.
    Zheng Y; Zheng H; Guo Z
    Heliyon; 2024 Jan; 10(1):e23194. PubMed ID: 38116192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
    He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.